Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
Cristina ArriensTeresa AberleFredonna CarthenStan KampAikaterini ThanouEliza ChakravartyJudith A JamesJoan T MerrillMotolani E OgunsanyaPublished in: Lupus science & medicine (2020)
Knowledge about potential benefits of clinical trial participation was high. Minority patients demonstrated confidence in making their own informed decisions, but major barriers for all participants included burdensome forms, travel, childcare, and work. These suggest a major impact on minority and all recruitment from behavioural and control aspects, which should be considered in the logistics of trial design. This does not minimise the potential importance of improved access and education about clinical research.
Keyphrases
- clinical trial
- healthcare
- phase ii
- study protocol
- phase iii
- physical activity
- end stage renal disease
- ejection fraction
- newly diagnosed
- systemic lupus erythematosus
- open label
- primary care
- randomized controlled trial
- prognostic factors
- case report
- rheumatoid arthritis
- quality improvement
- risk assessment
- disease activity